Dec. 11, 2002 — The U.S. Department of Defense awarded BioForce Nanosciences Inc. a grant for breast cancer research.
null
The award, managed by the Defense Department’s Army Medical Research and Materiel Command, aims to build a nanoscale protein array platform for studying alterations in cellular signaling pathways that accompany breast cancer research. The Iowa-based firm’s technology allows for a vast reduction in the amount of material needed for such analysis, according to a company news release.
null
The research is designed to provide useful information for developing sensitive breast cancer screening tests, monitoring clinical disease progression, defining drug targets and monitoring patients’ responses to drugs, the release said.